Fidelity Investments
PPH icon

Fidelity Investments’s VanEck Pharmaceutical ETF PPH Stock Holding History

Fidelity Investments’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Buy
3,341
+857
+35% +$88.7K ﹤0.01% 3416
2026
Q1 		$258K Buy
2,484
+425
+21% +$45.3K ﹤0.01% 3381
2025
Q4 		$212K Sell
2,059
-140
-6% -$13.6K ﹤0.01% 3410
2025
Q3 		$199K Buy
2,199
+738
+51% +$64.6K ﹤0.01% 3340
2025
Q2 		$129K Sell
1,461
-39
-3% -$3.38K ﹤0.01% 3489
2025
Q1 		$137K Sell
1,500
-473
-24% -$42.6K ﹤0.01% 3417
2024
Q4 		$170K Buy
1,973
+68
+4% +$6.15K ﹤0.01% 3332
2024
Q3 		$181K Buy
1,905
+212
+13% +$20.1K ﹤0.01% 3226
2024
Q2 		$155K Buy
1,693
+476
+39% +$42.5K ﹤0.01% 3120
2024
Q1 		$110K Buy
1,217
+985
+425% +$86.2K ﹤0.01% 3242
2023
Q4 		$18.9K Buy
232
+15
+7% +$1.18K ﹤0.01% 3975
2023
Q3 		$17.3K Hold
217
– – ﹤0.01% 3873
2023
Q2 		$17.1K Hold
217
– – ﹤0.01% 3930
2023
Q1 		$16.8K Buy
217
+51
+31% +$3.93K ﹤0.01% 3916
2022
Q4 		$12.9K Sell
166
-148
-47% -$10.9K ﹤0.01% 3923
2022
Q3 		$21K Buy
314
+23
+8% +$1.69K ﹤0.01% 3837
2022
Q2 		$22K Buy
291
+16
+6% +$1.25K ﹤0.01% 3846
2022
Q1 		$22K Buy
275
+75
+38% +$5.74K ﹤0.01% 3976
2021
Q4 		$15K Hold
200
– – ﹤0.01% 3538
2021
Q3 		$15K Hold
200
– – ﹤0.01% 3518
2021
Q2 		$15K Hold
200
– – ﹤0.01% 3456
2021
Q1 		$14K Hold
200
– – ﹤0.01% 3319
2020
Q4 		$13K Hold
200
– – ﹤0.01% 3263
2020
Q3 		$12K Hold
200
– – ﹤0.01% 3161
2020
Q2 		$12K Sell
200
-1
-0.5% -$60 ﹤0.01% 3085
2020
Q1 		$11K Hold
201
– – ﹤0.01% 3090
2019
Q4 		$13K Buy
201
+1
+0.5% +$60 ﹤0.01% 3211
2019
Q3 		$11K Hold
200
– – ﹤0.01% 3215
2019
Q2 		$12K Hold
200
– – ﹤0.01% 3200
2019
Q1 		$12K Buy
+200
New +$11.8K ﹤0.01% 3089

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Fidelity Investments's PPH Position: Q2 2026 in Review

Fidelity Investments increased its VanEck Pharmaceutical ETF (PPH) stake by 35% in Q2 2026, buying an estimated $88.7K and bringing the position to 3,341 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #3416.

Fidelity Investments first reported a position in PPH in Q1 2019 and has held it in 30 quarters since. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Fidelity Investments held 3,341 shares of VanEck Pharmaceutical ETF worth $365K as of Q2 2026.
  • Fidelity Investments bought 857 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $88.7K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3416 holding.
  • Fidelity Investments first reported a position in VanEck Pharmaceutical ETF in Q1 2019 and has held it in 30 quarters since.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.